Journal article

Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST

GD Demetri, AT van Oosterom, M Blackstein, C Garrett, M Shah, M Heinrich, G McArthur, I Judson, CM Baum, PG Casali

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2005